Is Ruxolitinib cream effective in treating vitiligo?

Ruxolitinib cream is a topical treatment for vitiligo. Its main component, Ruxolitinib, is a JAK inhibitor that can regulate immune and inflammatory responses. Some studies have shown that ruxolitinib cream has a positive effect on the treatment of vitiligo. But each person’s condition and response to treatment may be different. Although ruxolitinib cream has achieved good therapeutic results in some cases, it does not mean that it is effective in all patients.

Vitiligo is a chronic autoimmune disease that causes skin depigmentation and reduced quality of life. There are no approved treatments for vitiligo pigmentation, and current off-label treatments have limited effectiveness, emphasizing the need for improved treatment options. In a clinical study of up to52 weeks of treatment, ruxolitinib cream treatment was associated with substantial hyperpigmentation of vitiligo lesions and was well tolerated at all doses. Ruxolitinib cream treatment reduced lesion area proportionally in patients with vitiligo and also had an improvement effect in patients with severe hair and eyebrow damage. These data suggest that ruxolitinib cream may be an effective treatment option for patients with vitiligo.

The original drug of ruxolitinib cream has not yet been marketed in China, so it cannot be included in medical insurance. The price of ruxolitinib cream Original drug, specificationsinn 1.5%*60g, which is marketed overseas, is around RMB 20,000 per tube (the price may fluctuate due to the exchange rate), which is relatively expensive. The price of generic ruxolitinib cream marketed overseas is relatively cheap, and its pharmaceutical ingredients are basically the same as those of the original drug. The price of the specificationinn 1.5%*30g produced by a Bangladesh pharmaceutical factory is around 600 yuan per tube (the price may fluctuate due to exchange rate effects).